Hemodynamic maladjustment and disease progression in nephrosis with FSGS

Renal Failure

Volumn 26, Issue 3, 2004, Pages 231-236

  Futrakul, Narisa ^a   Siriviriyakul, Prasong ^a   Deekajorndej, Tawatchai ^a   Futrakul, Prasit ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Focal segmental glomerulosclerosis; Hemodynamics; Intraglomerular hypertension; Tubular function; Vasodilators

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ENALAPRIL; ISRADIPINE; LOSARTAN; MAGNESIUM; PENTETATE TECHNETIUM TC 99M; PREDNISOLONE; PROTEIN; VITAMIN D;

ARTICLE; BLOOD PRESSURE; CAPILLARY FLOW; CLINICAL ARTICLE; CREATININE CLEARANCE; DISEASE COURSE; FOLLOW UP; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; NEPHROSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; ULTRAFILTRATION; VASCULAR RESISTANCE;

DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY FUNCTION TESTS; NEPHROTIC SYNDROME; TIME FACTORS; VASODILATOR AGENTS;

EID: 3943086279     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120039520     Document Type: Article

References (30)

1. Glassock, R.J. Therapy of idiopathic nephrotic syndrome in adults. Am. J. Nephrol. 1993, 13, 422-428.
2. Cameron, J.S.; Turner, D.R.; Ogg, C.S.; Chantler, C.; Williams, D.G. The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin. Nephrol. 1978, 10, 213-218.
3. Wehrmann, M.; Bohle, A.; Held, H.; Schumm, G.; Kendziorra, H.; Pressler, H. Long-term prognosis of focal sclerosing glomerulonephritis: an analysis of 250 cases with particular regard to tubulointerstitial changes. Clin. Nephrol. 1990, 33, 115-122.
4. Baldwin, D.S. Chronic glomerulonephritis: non immunologic mechanisms of progressive glomerular damage. Kidney Int. 1982, 27, 109-120.
5. Futrakul, P.; Yenrudi, S.; Futrakul, N.; Sensirivatana, R.; Kingwatanakul, P.; Jungthirapanich, J.; Cherdkiadtikul, T.; Laohapaibul, A.; Watana, D.; Singkhwa, V.; Futrakul, S.; Pongsin, P. Tubular function and tubulointerstitial disease. Am. J. Kidney Dis. 1999, 33, 886-891.
6. Futrakul, P.; Poshyachinda, M.; Mitrakul, C. Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study. Clin. Nephrol. 1978, 10, 180-186.
7. Scandling, J.S.; Black, V.M.; Deen, W.M.; Myers, B.D. Glomerular perm selectivity in healthy and nephrotic humans. Adv. Nephrol. 1992, 21, 159-176.
8. Futrakul, P.; Futrakul, N.; Sitprija, V. Enhanced renal perfusion improves function in severe nephrosis with focal segmental glomerulosclerosis. Nephrology 1995, 7, 51-57.
9. Yenrudi, S.; Laohapaibul, A.; Kittidiwit, W.; Suteparuk, S.; Futrakul, N. A correlation between renal morphology and renal circulation in pediatric nephrotic syndrome. Ren. Fail. 2001, 23, 85-90.
10. Bohle, A.; Mackensen-Haen, S.; Wehrmann, M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press. Res. 1996, 19, 191-195.
11. Futrakul, N.; Kittidiwit, W.; Yenrudi, S. Reduced endothelial factor VIII staining in renal micro-circulation correlates with hemodynamic alteration in nephrosis. Ren Fail. 2003, 25, 759-764.
12. Futrakul, P.; Sitprija, V.; Yenrudi, S.; Poshyachinda, M.; Sensirivatana, R.; Watana, D.; Singklwa, V.; Jungthirapanich, J.; Futrakul, N. Glomerular endothelial dysfunction determines disease progression: a hypothesis. Am. J. Nephrol. 1997, 17, 533-540.
13. Futrakul, N.; Tosukhowong, P.; Valyapongpichit, Y.; Tipprukmas, N.; Futrakul, P.; Patumraj, S. Oxidative stress and hemodynamic maladjustment in chronic renal disease: a therapeutic implication. Ren. Fail. 2002, 24, 433-445.
14. Futrakul, P.; Poshyachinda, M.; Futrakul, N.; Chaiwatanarat, T.; Sensirivatana, R.; Thamaree, S.; Watana, D.; Kingwatanakul, P. Intrarenal hemodynamic alterations and tubular functions in nephrotic syndrome associated with focal segmental glomerulosclerosis (FSGS): a pathogenetic and therapeutic implication. In Current Therapy in Nephrology; Andreucci, V.E., Dal Canton, A., Eds.; Wichtig: Milan, 1993; 107-114.
15. Guasch, A.; Sibley, R.K.; Huie, P.; Myers, B.D. Extent and course of glomerular injury in human membranous glomerulopathy. Am. J. Physiol. 1992, 263, F1034-F1043.
16. Futrakul, N.; Panichakul, T.; Chaisuriya, P.; Sirisinha, S.; Patumraj, S.; Futrakul, P. Endothelial cell cytotoxicity and renal hypoperfusion in idiopathic nephrotic syndrome. Nephron 2000, 86, 241-242.
17. Futrakul, N.; Butthep, P.; Patumraj, S.; Tipprukmas, N.; Futrakul, P. Enhanced tumor necrosis factor in the serum and renal hypoperfusion in nephrosis associated with focal segmental glomerulosclerosis. Ren. Fail. 2000, 22, 213-217.
18. Futrakul, P.; Poshyachinda, M.; Yenrudi, S.; Seleekul, P.; Sensirivatana, R.; Futrakul, N. Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: therapeutic benefit with vasodilators. J. Med. Assoc. Thai. 1992, 75, 375-385.
19. Futrakul, N.; Laohapaibul, A.; Futrakul, P. Glomerular endothelial dysfunction and hemodynamic Maladjustment in Vesicoureteric Reflex. Ren. Fail. 2003, 25, 479-483.
20. Kriz, W.; Elger, M.; Nagata, M.; Kretzlar, M.; Uiker, S.; Koeppen-Hagemann, I.; Tenschert, S.; Lemley, K.V. The role of podocytes in the development of glomerulosclerosis. Kidney Int. 1994, 45 (suppl 45), 64-72.
21. Rennke, H.G. How does glomerular epithelial injury contribute to progressive glomerular damage? Kidney Int. 1994, 45 (suppl 45), 58-63.
22. Fogo, A. Nephrotic syndrome: molecular and genetic basis. Nephron 2000, 85, 8-13.
23. Fan, L.; Wakayama, T.; Yokoyama, S.; Amano, O.; Iseki, S. Down-regulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis. Nephron 2002, 90, 95-102.
24. Lemley, K.V.; Lafayetti, R.A.; Safai, M.; Derby, G.; Blouch, K.; Squarer, A.; Myers, B.D. Podocytopenia and disease severity in IgA nephropathy. Kidney Int. 2002, 61, 1475-1485.
25. Fogo, A.B. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am. J. Kidney Dis. 2000, 35, 179-188.
26. Bottinger, E.P.; Bitzer, M. TGF-B signaling in renal disease. J. Am. Soc. Nephrol. 2002, 13, 260-269.
27. Ruiz-Ortega, M.; Egido, J. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int. 1997, 52, 1497-1510.
28. Komine, N.; Khang, S.; Wead, L.M.; Blantz, R.C.; Gubbar, F.B. Effect of combining an ACE inhibitor and angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels. Am. J. Kidney Dis. 2002, 39, 159-164.
29. Remuzzi, A.; Gagliardini, E.; Donadino, C.; Fassi, A.; Sanzalli, F.; Lepre, M.S.; Remuzzi, G.; Benigni, A. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int. 2002, 62, 885-894.
30. Futrakul, N.; Yenrudi, S.; Futrakul, P.; Cherdkiadtikul, T.; Laohapaibul, A.; Futrakul, S.; Sensirivatana, R. Peritubular capillary flow and tubular function in idiopathic nephrotic syndrome. Nephron 2000, 85, 181-182.